Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 28, 2026
Why Is Commvault Systems (CVLT) Stock Down -15.94% Today?

Why Is Commvault Systems (CVLT) Stock Down -15.94% Today?

Key Takeaways

  • Commvault Systems stock tumbled 15.94% in midday trading Tuesday, erasing roughly $1 billion in market value despite posting fiscal first-quarter results that topped Wall Street profit and revenue estimates.
  • Annual Recurring Revenue (ARR) missed analyst expectations, coming in at $1.054 billion versus the $1.15 billion consensus, while billings declined 5.9% year over year.
  • Piper Sandler downgraded the stock from Overweight to Neutral with a $133 price target, citing limited catalysts ahead after the company's guidance failed to impress.
  • A sharp free cash flow margin contraction — from 42.3% in the prior quarter to 16.3% — added to investor unease about the quality of the earnings beat.
  • The selloff is entirely stock-specific, with the iShares Expanded Tech-Software Sector ETF (IGV) rising over 1.8% and the S&P 500 in positive territory during the same session.
  • Traders are now watching for whether management can rebuild credibility on ARR growth predictability and whether the September-quarter guidance signals a reacceleration or further deceleration.

Opening Summary

CVLT, the stock of Commvault Systems, Inc. — a Tinton Falls, New Jersey-based provider of cyber resilience and data protection software for enterprises — plunged sharply on Tuesday, dropping 15.94% to approximately $125.63 as of midday trading. The decline followed the release of the company's fiscal first-quarter 2027 results, which covered the period ended June 30, 2026. While headline adjusted earnings per share of $1.42 and revenue of $314.1 million both surpassed consensus forecasts, investors seized on weaker-than-expected Annual Recurring Revenue, contracting billings, and a Piper Sandler downgrade, triggering a broad-based selloff that more than erased Monday's 5% pre-earnings rally.

Earnings Beat Overshadowed by ARR and Billings Misses

At first glance, Commvault's fiscal Q1 2027 results appeared strong. Adjusted EPS of $1.42 sailed past the $1.16 consensus by 22%, while total revenue of $314.1 million grew 11% year over year and edged above the $310.5 million Wall Street estimate. Subscription revenue climbed 16% to a record $267 million, and SaaS revenue crossed the $100 million threshold for the first time, surging 39% year over year. Management also raised its full-year non-GAAP EBIT margin guidance by 50 basis points to approximately 21%.

Yet the stock plummeted because the market was focused on a different set of numbers. Subscription Annual Recurring Revenue — arguably the single most important metric for a SaaS-transitioning software company — came in at $1.054 billion, well short of the $1.15 billion analysts had projected. Billings of $301.8 million represented a 5.9% year-over-year decline and also missed expectations. Free cash flow margin compressed dramatically to 16.3%, down from 42.3% in the prior quarter. On a GAAP basis, net income actually fell to $21.1 million from $23.5 million a year ago, reflecting the ongoing investment cycle.

Piper Sandler Downgrade Amplifies Selling Pressure

Compounding the post-earnings selloff, Piper Sandler downgraded CVLT from Overweight to Neutral while maintaining a $133 price target, which sat well below Monday's closing price of $149.46. The firm noted that its prior bullish thesis "did not pan out as expected" and cited limited near-term catalysts. The downgrade carried particular weight given Piper Sandler had upgraded the stock to Overweight in October 2025. Analyst Howard Ma had flagged "caution on the near-term setup" ahead of the report, and the lack of a guidance raise — combined with what the firm characterized as conservative outlook numbers — validated that cautious stance.

Growth Deceleration and Credibility Concerns

Commvault entered Tuesday's session carrying significant baggage. The stock suffered a 31% single-day crash in January 2026 after the company disclosed that fiscal Q3 net new ARR of $39 million had missed its own $45 million target. That event triggered a securities class action lawsuit, multiple analyst downgrades, and lingering skepticism about the reliability of management's ARR growth projections. The lawsuit, which alleges that Commvault failed to properly account for how a shift toward lower-priced SaaS deals would mechanically dilute ARR figures, has kept a cloud over the stock even as shares staged a remarkable 70% rally from late April through Monday.

Against that backdrop, Tuesday's report needed to deliver unequivocal strength on the ARR line. Instead, the modest ARR miss and declining billings reinforced doubts about whether the company can sustain the growth cadence investors had priced in. Revenue growth decelerated to 11% from the 26% pace of the year-ago quarter, and term-based license revenue grew just 1%, signaling that the on-premises segment of the business continues to plateau. Management acknowledged that hardware availability constraints and foreign exchange headwinds each exerted modest pressure on net new ARR during the quarter.

Market Context and Trading Activity

The magnitude of CVLT's decline is particularly stark in context. The broader software sector, as measured by the IGV ETF, was up more than 1.8% during Tuesday's session, while the SPY S&P 500 ETF and QQQ Nasdaq-100 ETF were essentially flat to slightly positive. This confirms the move is entirely company-specific rather than driven by macro or sector headwinds. Trading volume in CVLT was elevated well above the daily average, reflecting the intensity of the institutional repositioning. The stock breached its 50-day moving average and was testing levels last seen in late April, before the prior quarter's earnings-driven rally began.

What Comes Next for CVLT

Looking ahead, Commvault's fiscal second-quarter guidance calls for subscription revenue between $264 million and $268 million and total revenue of approximately $310 million, with a non-GAAP EBIT margin of roughly 20%. The full-year outlook was maintained: total revenue of $1.30 billion to $1.31 billion, subscription revenue of $1.119 billion to $1.129 billion, and subscription ARR of $1.20 billion to $1.21 billion. The company expects SaaS ARR to exceed $500 million by fiscal year-end.

The key question for investors is whether the $39 million in net new subscription ARR delivered in Q1 represents a bottom, or whether the SaaS mix-shift dynamics that have pressured ARR will continue to weigh on reported growth metrics. Management expressed confidence on the earnings call that AI-driven demand for data protection, identity resilience, and cyber recovery creates a durable tailwind. The Microsoft Azure partnership expansion and the upcoming launch of AI Studio, Data Activate, and AI Protect products provide incremental narrative support. However, until Commvault can deliver consecutive quarters of clean ARR beats against guidance, the stock is likely to remain under a credibility discount despite the company's improving profitability profile.

Trending AI Robots

For traders seeking systematic approaches to navigate sharp earnings-driven moves like the one in CVLT, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron hosts hundreds of bots covering thousands of tickers across multiple strategies and timeframes, but only the strongest performers under current market conditions are featured in this dynamically updated section. Each bot varies by strategy type, performance metrics, and traded symbols, allowing users to explore automated trading approaches that align with their own risk tolerance and market outlook. Visit the Trending AI Robots page to discover which strategies are generating leading risk-adjusted returns in today's environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CVLT

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


CVLT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for CVLT moved above the 200-day moving average on July 09, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CVLT's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 11, 2026. You may want to consider a long position or call options on CVLT as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CVLT just turned positive on August 11, 2026. Looking at past instances where CVLT's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

CVLT moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVLT advanced for three days, in of 382 cases, the price rose further within the following month. The odds of a continued upward trend are .

CVLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for CVLT crossed bearishly below the 50-day moving average on August 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVLT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CVLT entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVLT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (111.111) is normal, around the industry mean (28.479). P/E Ratio (89.345) is within average values for comparable stocks, (81.364). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.725). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (5.020) is also within normal values, averaging (69.517).

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.31B. The market cap for tickers in the group ranges from 291 to 239.15B. SAP holds the highest valuation in this group at 239.15B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 8%. YXT experienced the highest price growth at 62%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 4% and the average quarterly volume growth was -61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
CVLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of data and information management software applications and services

Industry PackagedSoftware

Profile
Details
Industry
Packaged Software
Address
1 CommVault Way
Phone
+1 732 870-4000
Employees
3300
Web
https://www.commvault.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.